```json { "scores": [ { "id": "cnv_0e9003ee203d45a6", "score": 72, "tier": "regular", "rationale": "Clear orientation to dataset scope and row definition. Lacks specificity on column count discrepancy (says 6, actual is 10)." }, { "id": "cnv_55b27ed2effa4c03", "score": 85, "tier": "great", "rationale": "Concrete dimensions (171 rows, 6 columns), precise date range, 97 distinct dates. Actionable baseline for all downstream analysis." }, { "id": "cnv_5027020758ae486f", "score": 68, "tier": "regular", "rationale": "Lists columns with examples and ranges. Useful reference but incomplete (claims 10 columns, earlier said 6). Lacks clarity on data types." }, { "id": "cnv_5d0c3d959639473d", "score": 75, "tier": "regular", "rationale": "Solid taxonomy of column roles. Identifies 127 companies, 58 industries, 126 investors. Useful for understanding structure but somewhat mechanical." }, { "id": "cnv_87326156188047c2", "score": 78, "tier": "regular", "rationale": "Shows top deals (OpenAI $10B, Stripe $6.5B) with dates and investors. Concrete examples ground understanding but lacks statistical depth." }, { "id": "cnv_60e976c04c214cc7", "score": 82, "tier": "great", "rationale": "Definitive finding: zero missing values across all 10 columns. Critical for data quality assessment and downstream analysis confidence." }, { "id": "cnv_ed2e14e8415d4422", "score": 80, "tier": "great", "rationale": "Confirms zero duplicates across 171 rows. Essential quality assurance. Explains why duplicates wouldn't be expected given deal structure." }, { "id": "cnv_0cb38c928fb44dc9", "score": 65, "tier": "regular", "rationale": "Distinct value counts for categorical columns (127 companies, 126 investors, 58 industries). Useful reference but lacks insight into concentration." }, { "id": "cnv_ef50bc30852a433d", "score": 88, "tier": "great", "rationale": "Precise distributions: Amount $100M–$10B (mean $301M, median $150M); Valuation $500M–$50B but only 27% populated. High-value summary for analysis." }, { "id": "cnv_14e96ddafb44468d", "score": 90, "tier": "great", "rationale": "Identifies 7 format inconsistencies in Amount, 70% missing Valuation data, mixed investor formats. Concrete quality issues with actionable implications." }, { "id": "cnv_36ec901808b4474d", "score": 87, "tier": "great", "rationale": "Biotech dominates (42 deals, 24.6%), AI second (21 deals, 12.3%). Top 5 industries = 51% of deals. Specific, surprising, actionable segmentation." }, { "id": "cnv_940bde884e5a45ee", "score": 84, "tier": "great", "rationale": "Amount–Valuation correlation r=0.76 with caveat on 27% data coverage. Concrete finding with proper context on limitations." }, { "id": "cnv_1e20595ab86b4730", "score": 86, "tier": "great", "rationale": "Identifies Amount as primary metric. Top deal: OpenAI $10B (AI), second: Stripe $6.5B (fintech). Concrete extremes with industry context." }, { "id": "cnv_2c0ff25577bf4ee7", "score": 89, "tier": "great", "rationale": "Clear temporal trend: flat Jan–May, dip July (6 deals), surge Aug–Sep (27 deals each). Specific monthly breakdown reveals acceleration pattern." }, { "id": "cnv_033334a3ce444b9f", "score": 91, "tier": "great", "rationale": "Identifies three mega-deals ($18.5B = 40% of total): Jan 23 ($10B), Mar 15 ($6.5B), Jun 29 ($1.54B). Concrete outliers with precise dates and amounts." }, { "id": "cnv_caaa4bd1ed844fcb", "score": 89, "tier": "great", "rationale": "AI captured $15.78B (21 deals), Biotech $6.7B (42 deals). Fintech highest avg ($1.24B/deal). Reveals capital concentration by sector with specificity." }, { "id": "cnv_88b793955e8d446c", "score": 85, "tier": "great", "rationale": "Proposes Industry as primary segmentation (63 sectors), Time as secondary. Biotech 42 deals, AI $15.8B. Actionable grouping strategy with evidence." }, { "id": "cnv_2bb9562825ff4114", "score": 60, "tier": "not_useful", "rationale": "Correctly identifies no geographic dimension. Useful clarification but low-signal—mostly eliminates a false assumption rather than revealing insight." }, { "id": "cnv_33b31553f04249d6", "score": 92, "tier": "great", "rationale": "Counterintuitive finding: Biotech 42 deals ($6.7B avg $160M) vs AI 21 deals ($15.8B avg $751M). AI deals 5x larger despite half the volume. Surprising, specific, actionable." }, { "id": "cnv_5af6fad3b70040df", "score": 72, "tier": "regular", "rationale": "Proposes 3 analytical questions (industry variation, funding trends, investor patterns). Useful framing but generic—doesn't answer questions, only poses them." } ] } ```